BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,082,241 | -17.4% | 267,150 | -0.3% | 0.08% | -10.9% |
| Q2 2023 | $12,203,246 | +11.5% | 267,850 | -0.8% | 0.09% | +10.8% |
| Q1 2023 | $10,946,130 | -21.7% | 269,875 | -1.6% | 0.08% | -23.9% |
| Q4 2022 | $13,981,071 | -4.9% | 274,300 | +0.5% | 0.11% | -9.9% |
| Q3 2022 | $14,701,000 | -20.1% | 272,950 | -4.8% | 0.12% | -14.2% |
| Q2 2022 | $18,407,000 | -15.6% | 286,574 | +1.8% | 0.14% | -1.4% |
| Q1 2022 | $21,818,000 | -4.2% | 281,374 | +6.0% | 0.14% | -0.7% |
| Q4 2021 | $22,786,000 | +34.4% | 265,449 | +25.9% | 0.14% | +28.6% |
| Q3 2021 | $16,958,000 | -0.1% | 210,842 | +0.0% | 0.11% | +3.7% |
| Q2 2021 | $16,967,000 | -4.4% | 210,776 | +0.2% | 0.11% | -9.2% |
| Q1 2021 | $17,749,000 | +3.6% | 210,446 | -1.4% | 0.12% | -2.5% |
| Q4 2020 | $17,125,000 | -0.5% | 213,425 | -0.2% | 0.12% | -9.0% |
| Q3 2020 | $17,206,000 | -6.7% | 213,950 | -0.1% | 0.13% | -10.7% |
| Q2 2020 | $18,434,000 | +6.0% | 214,100 | -0.0% | 0.15% | -3.2% |
| Q1 2020 | $17,391,000 | -5.9% | 214,200 | -3.0% | 0.16% | +30.3% |
| Q4 2019 | $18,472,000 | -5.3% | 220,900 | -0.9% | 0.12% | -7.8% |
| Q3 2019 | $19,506,000 | -2.0% | 223,000 | -8.2% | 0.13% | +0.8% |
| Q2 2019 | $19,902,000 | +2.8% | 243,000 | +2.1% | 0.13% | +4.9% |
| Q1 2019 | $19,352,000 | +21.0% | 238,000 | -2.1% | 0.12% | +10.9% |
| Q4 2018 | $15,994,000 | -2.6% | 243,000 | +14.1% | 0.11% | +17.0% |
| Q3 2018 | $16,420,000 | +1.1% | 213,000 | -3.2% | 0.09% | -2.1% |
| Q2 2018 | $16,245,000 | +6.4% | 220,000 | -6.3% | 0.10% | +5.5% |
| Q1 2018 | $15,266,000 | -9.5% | 234,722 | -10.1% | 0.09% | -6.2% |
| Q4 2017 | $16,874,000 | +3.0% | 261,050 | 0.0% | 0.10% | +3.2% |
| Q3 2017 | $16,381,000 | +3.7% | 261,050 | 0.0% | 0.09% | 0.0% |
| Q2 2017 | $15,804,000 | +16.7% | 261,050 | 0.0% | 0.09% | +17.5% |
| Q1 2017 | $13,538,000 | +17.0% | 261,050 | 0.0% | 0.08% | +17.6% |
| Q4 2016 | $11,575,000 | -6.8% | 261,050 | 0.0% | 0.07% | -8.1% |
| Q3 2016 | $12,426,000 | -25.8% | 261,050 | -29.5% | 0.07% | -25.3% |
| Q2 2016 | $16,737,000 | -3.7% | 370,116 | -12.5% | 0.10% | -5.7% |
| Q1 2016 | $17,373,000 | +15.6% | 422,899 | +7.3% | 0.10% | +15.4% |
| Q4 2015 | $15,034,000 | +16.1% | 394,066 | 0.0% | 0.09% | +18.2% |
| Q3 2015 | $12,945,000 | -55.7% | 394,066 | -5.7% | 0.08% | -49.7% |
| Q2 2015 | $29,235,000 | +40.9% | 418,066 | +38.0% | 0.15% | +45.7% |
| Q1 2015 | $20,756,000 | -13.1% | 303,000 | -7.1% | 0.10% | -9.5% |
| Q4 2014 | $23,893,000 | -0.1% | 326,000 | -2.2% | 0.12% | -4.1% |
| Q3 2014 | $23,928,000 | +0.8% | 333,400 | +1.5% | 0.12% | +3.4% |
| Q2 2014 | $23,743,000 | -1.7% | 328,400 | 0.0% | 0.12% | -6.4% |
| Q1 2014 | $24,164,000 | +19.0% | 328,400 | +12.5% | 0.12% | +15.7% |
| Q4 2013 | $20,309,000 | +12.6% | 292,000 | +6.4% | 0.11% | +4.9% |
| Q3 2013 | $18,032,000 | +1.3% | 274,500 | +6.8% | 0.10% | -4.6% |
| Q2 2013 | $17,802,000 | – | 257,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |